Rocket Lab has navigated a paradoxical 30 days marked by operational strength offsetting equity weakness. The company posted 63 percent revenue growth while shares declined 30 percent, reflecting investor skepticism toward growth-stage aerospace valuations amid macro headwinds. The dominant narrative centers on the company's Iridium Communications acquisition, which cleared Hart-Scott-Rodino review in mid-August, removing a key regulatory hurdle despite remaining FCC scrutiny. Separately, Rocket Lab's German subsidiary launch signals European expansion ambitions aligned with sovereign space capability demands. Key catalysts include Q2 earnings results, which revealed revenue momentum but failed to arrest selling pressure. A Morgan Stanley bull case reaching $293 contrasts sharply with Street consensus at $111, indicating significant valuation dispersion. The broader space sector rallied following a Wall Street upgrade in early August, though Rocket Lab underperformed peers, suggesting sector-specific concerns persist. Forward momentum depends on acquisition closure timing and demonstrating Iridium synergy value. Success could unlock institutional reallocation toward integrated space infrastructure plays.